Gemcitabine for Marginal Zone Lymphoma
Clinical trial NCT00337259 · TERMINATED
Trial details
- NCT number
- NCT00337259
- Sponsor
- Asan Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2009-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.